Tag archive for ‘4-Antibody’
Agenus: Its R&D Day Presentation Puts a Focus on the Great Promise of Cancer Vaccines and Checkpoint Modulators (AGEN, Buy, $6.73)
Overview of Report I found the Agenus R&D day to be extremely interesting as it showcased the impressive immunotherapy technology base of Agenus. Presentations by management and key opinion leaders went into great detail on the Company’s core Prophage cancer vaccine and checkpoint modulator technologies. I have included bullet points on remarks that most interested […]
Agenus: There Has Been a Positive,Transformational Change in the Investment Thesis (AGEN, $3.67)
This note is based on a presentation that was made by Bob Stein at the BIOCEO conference: he is the new chief medical officer of Agenus (AGEN). It was provided to paid subscribers in my note on BIO CEO highlights on February 14, 2014. He spoke almost entirely about the recent acquisition of the privately […]